{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:31:04Z","timestamp":1758709864328},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T00:00:00Z","timestamp":1473379200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00105-016-3873-4","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T06:04:34Z","timestamp":1473401074000},"page":"867-875","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Aktinische Keratosen"],"prefix":"10.1007","volume":"67","author":[{"given":"T.","family":"Hommel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.-M.","family":"Szeimies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"3873_CR1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jdv.12102","volume":"28","author":"I Schaefer","year":"2014","unstructured":"Schaefer I, Augustin M, Spehr C et\u00a0al (2014) Prevalence and risk factors of actinic keratoses in Germany \u2013 analysis of multisource data. J\u00a0Eur Acad Dermatol Venereol 28:309\u2013313","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00105-014-2759-6","volume":"65","author":"T Strunk","year":"2014","unstructured":"Strunk T, Szeimies RM (2014) Aktinische Keratosen. Pathogenese, Klinik und moderne Therapieoptionen. Hautarzt 65:241\u2013252","journal-title":"Hautarzt"},{"key":"3873_CR3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1046\/j.1365-2133.2000.03541.x","volume":"142","author":"AA Memon","year":"2000","unstructured":"Memon AA, Tomenson JA, Bothwell J et\u00a0al (2000) Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 142:1154\u20131159","journal-title":"Br J Dermatol"},{"key":"3873_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13555-015-0070-9","volume":"5","author":"P Chetty","year":"2015","unstructured":"Chetty P, Choi F, Mitchell T et\u00a0al (2015) Primary care review of actinic keratosis and its therapeutic options: a global perspective. Dermatol Ther 5:19\u201335","journal-title":"Dermatol Ther"},{"key":"3873_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2133.2010.10118.x","volume":"164","author":"J Schmitt","year":"2011","unstructured":"Schmitt J, Seidler A, Diepgen TL et al (2011) Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol 164:291\u2013307","journal-title":"Br J Dermatol"},{"key":"3873_CR6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00403-013-1384-z","volume":"305","author":"M Oldenburg","year":"2013","unstructured":"Oldenburg M, Kuechmeister B, Ohnemus U et\u00a0al (2013) Actinic keratosis among seafarers. Arch Dermatol Res 305:787\u2013796","journal-title":"Arch Dermatol Res"},{"key":"3873_CR7","first-page":"51","volume":"37","author":"L Miligi","year":"2013","unstructured":"Miligi L, Benvenuti A, Legittimo P et\u00a0al (2013) Solar ultraviolet radiation risk in outdoor workers: a specific project of Tuscany region (Italy). Epidemiol Prev 37:51\u201359","journal-title":"Epidemiol Prev"},{"issue":"Suppl 3","key":"3873_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdv.13603","volume":"30","author":"M Trakatelli","year":"2016","unstructured":"Trakatelli M, Barkitzi K, Apap C (2016) Skin cancer risk in outdoor workers: a European multicenter case-control study. J Eur Acad Dermatol Venereol 30(Suppl 3):5\u201311","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR9","first-page":"1102","volume":"12","author":"TL Diepgen","year":"2014","unstructured":"Diepgen TL, Brandenburg S, Aberer W et al (2014) Skin cancer induced by natural UV-radiation as an occupational disease-requirements for its notification and recognition. J Dtsch Dermatol Ges 12:1102\u20131106","journal-title":"J Dtsch Dermatol Ges"},{"key":"3873_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1684\/ejd.2016.2758","volume":"26","author":"RA Kaufmann","year":"2016","unstructured":"Kaufmann RA, Oberholzer PA, Cazzaniga S (2016) Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients. Eur J Dermatol 26:265\u2013270","journal-title":"Eur J Dermatol"},{"key":"3873_CR11","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jid.2016.02.804","volume":"136","author":"MR Iannacone","year":"2016","unstructured":"Iannacone MR, Sinnya S, Pandeya N (2016) Prevalence of skin cancer and related skin tumors in high-risk kidney and liver transplant recipients in Queensland, Australia. J Invest Dermatol 136:1382\u20131386","journal-title":"J Invest Dermatol"},{"issue":"Suppl 2","key":"3873_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.0366-077X.2003.05633.x","volume":"149","author":"C Ulrich","year":"2003","unstructured":"Ulrich C, Schmook T, Nindl I et\u00a0al (2003) Cutaneous precancers in organ transplant recipients: an old enemy in a new surrounding. Br J Dermatol 149(Suppl 2):40\u201342","journal-title":"Br J Dermatol"},{"key":"3873_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaad.2010.11.063","volume":"65","author":"FO Zwald","year":"2011","unstructured":"Zwald FO, Brown M (2011) Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J\u00a0Am Acad Dermatol 65:263\u2013279","journal-title":"J Am Acad Dermatol"},{"key":"3873_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3315\/jdcr.2015.1199","volume":"9","author":"C Costa","year":"2015","unstructured":"Costa C, Scalvenzi M, Ayala F (2015) How to treat actinic keratosis? An update. J\u00a0Dermatol Case Rep 9:29\u201335","journal-title":"J Dermatol Case Rep"},{"key":"3873_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1986.tb06644.x","volume":"115","author":"R Marks","year":"1986","unstructured":"Marks R, Foley P, Goodman G et\u00a0al (1986) Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 115:649\u2013655","journal-title":"Br J Dermatol"},{"key":"3873_CR16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archderm.1991.01680060103013","volume":"127","author":"JM Dodson","year":"1991","unstructured":"Dodson JM, DeSpain J, Hewett JE et al (1991) Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 127:1029\u20131031","journal-title":"Arch Dermatol"},{"key":"3873_CR17","first-page":"1099","volume":"33","author":"A Fuchs","year":"2007","unstructured":"Fuchs A, Marmur E (2007) The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg 33:1099\u20131101","journal-title":"Dermatol Surg"},{"issue":"Suppl 3","key":"3873_CR18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","volume":"156","author":"J R\u00f6wert-Huber","year":"2007","unstructured":"R\u00f6wert-Huber J, Patel MJ, Forschner T et al (2007) Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 156(Suppl 3):8\u201312","journal-title":"Br J Dermatol"},{"key":"3873_CR19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jdv.12848","volume":"29","author":"MT Fernandez-Figueras","year":"2015","unstructured":"Fernandez-Figueras MT, Carrato C, Saenz X et al (2015) Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin. J Eur Acad Dermatol Venereol 29:991\u2013997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1684\/ejd.2009.0706","volume":"19","author":"P Hensen","year":"2009","unstructured":"Hensen P, M\u00fcller ML, Haschemi R et al (2009) Predisposing factors of actinic keratosis in a North-West German population. Eur J Dermatol 19:345\u2013354","journal-title":"Eur J Dermatol"},{"key":"3873_CR21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00105-003-0543-0","volume":"546","author":"P Babilas","year":"2003","unstructured":"Babilas P, Landthaler M, Szeimies RM (2003) Aktinische Keratosen. Hautarzt 546:551\u2013562","journal-title":"Hautarzt"},{"issue":"22","key":"3873_CR22","first-page":"8158","volume":"61","author":"JL Luo","year":"2001","unstructured":"Luo JL, Tong WM, Yoon JH et al (2001) UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin. Cancer Res 61(22):8158\u20138163","journal-title":"Cancer Res"},{"issue":"Suppl 2","key":"3873_CR23","first-page":"53","volume":"63","author":"D Tomas","year":"2009","unstructured":"Tomas D (2009) Apoptosis, UV-radiation, precancerosis and skin tumors. Acta Med Croatica 63(Suppl 2):53\u201358","journal-title":"Acta Med Croatica"},{"key":"3873_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5306\/wjco.v4.i4.85","volume":"4","author":"A Kivisaari","year":"2013","unstructured":"Kivisaari A, K\u00e4h\u00e4ri VM (2013) Squamous cell carcinoma of the skin: emerging need for novel biomarkers. World J Clin Oncol 4:85\u201390","journal-title":"World J Clin Oncol"},{"key":"3873_CR25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mc.2940040306","volume":"4","author":"WE Pierceall","year":"1991","unstructured":"Pierceall WE, Goldberg LH, Tainsky MA et\u00a0al (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4:196\u2013202","journal-title":"Mol Carcinog"},{"key":"3873_CR26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","volume":"122","author":"V Ratushny","year":"2012","unstructured":"Ratushny V, Gober MD, Hick R et\u00a0al (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J\u00a0Clin Invest 122:464\u2013472","journal-title":"J Clin Invest"},{"key":"3873_CR27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/archderm.1995.01690190048009","volume":"131","author":"JM Spencer","year":"1995","unstructured":"Spencer JM, Kahn SM, Jiang W et\u00a0al (1995) Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 131:796\u2013800","journal-title":"Arch Dermatol"},{"key":"3873_CR28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S et\u00a0al (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91:355\u2013358","journal-title":"Br J Cancer"},{"key":"3873_CR29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2014.376","volume":"135","author":"PM Riihil\u00e4","year":"2015","unstructured":"Riihil\u00e4 PM, Nissinen LM, Farshchian M (2015) Complement factor I promotes progression of cutaneous squamous cell carcinoma. J\u00a0Invest Dermatol 135:579\u2013588","journal-title":"J Invest Dermatol"},{"key":"3873_CR30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3091","volume":"46","author":"CS Lee","year":"2014","unstructured":"Lee CS, Bhaduri A, Mah A et\u00a0al (2014) Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma. Nat Genet 46:1060\u20131062","journal-title":"Nat Genet"},{"key":"3873_CR31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng1099","volume":"33","author":"M Nicolas","year":"2003","unstructured":"Nicolas M et\u00a0al (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33:416\u2013421","journal-title":"Nat Genet"},{"issue":"6237","key":"3873_CR32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Roshan A, Gerstung M (2015) Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348(6237):880\u2013886","journal-title":"Science"},{"key":"3873_CR33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2012.03.048","volume":"149","author":"B Hu","year":"2012","unstructured":"Hu B, Castillo E, Harewood L et\u00a0al (2012) Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. Cell 149:1207\u20131220","journal-title":"Cell"},{"key":"3873_CR34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ncb3228","volume":"17","author":"MG Procopio","year":"2015","unstructured":"Procopio MG, Csaba L, Al Labban D et al (2015) Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat Cell Biol 17:1193\u20131204","journal-title":"Nat. Cell Biol."},{"key":"3873_CR35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.lpm.2014.08.008","volume":"43","author":"R Accardi","year":"2014","unstructured":"Accardi R, Gheit T (2014) Cutaneous HPV and skin cancer. Presse Med 43:435\u2013443","journal-title":"Presse Med"},{"key":"3873_CR36","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.jid.5701227","volume":"128","author":"MM Asgari","year":"2008","unstructured":"Asgari MM, Kiviat NB, Critchlow CW et\u00a0al (2008) Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J\u00a0Invest Dermatol 128:1409\u20131417","journal-title":"J Invest Dermatol"},{"key":"3873_CR37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2014.01.857","volume":"70","author":"J Wang","year":"2014","unstructured":"Wang J, Aldabagh B, Yu J et al (2014) Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol 70:621\u2013629","journal-title":"J Am Acad Dermatol"},{"key":"3873_CR38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000437272","volume":"28","author":"J Krutmann","year":"2015","unstructured":"Krutmann J, Berking C, Berneburg M et\u00a0al (2015) New strategies in the prevention of actinic keratosis: a critical review. Skin Pharmacol Physiol 28:281\u2013289","journal-title":"Skin Pharmacol Physiol"},{"key":"3873_CR39","first-page":"429","volume":"810","author":"G Bens","year":"2014","unstructured":"Bens G (2014) Sunscreens. Adv Exp Med Biol 810:429\u2013463","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 3","key":"3873_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","volume":"161","author":"C Ulrich","year":"2009","unstructured":"Ulrich C, J\u00fcrgensen JS, Degen A et al (2009) Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24\u00a0months, prospective, case-control study. Br J Dermatol 161(Suppl 3):78\u201384","journal-title":"Br J Dermatol"},{"key":"3873_CR41","first-page":"2365","volume":"69","author":"MD Andrews","year":"2004","unstructured":"Andrews MD (2004) Cryosurgery for common skin conditions. Am Fam Physician 69:2365\u20132372","journal-title":"Am Fam Physician"},{"key":"3873_CR42","doi-asserted-by":"crossref","first-page":"e0123906","DOI":"10.1371\/journal.pone.0123906","volume":"10","author":"A Kasuya","year":"2015","unstructured":"Kasuya A, Ohta I, Tokura Y et\u00a0al (2015) Structural and immunological effects of skin cryoablation in a mouse model. PLOS ONE 10:e0123906","journal-title":"PLOS ONE"},{"key":"3873_CR43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1684\/ejd.2013.1923","volume":"23","author":"D Nashan","year":"2013","unstructured":"Nashan D, Meiss F, M\u00fcller M (2013) Therapeutic strategies for actinic keratoses \u2013 a systematic review. Eur J Dermatol 23:14\u201332","journal-title":"Eur J Dermatol"},{"key":"3873_CR44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00105-004-0865-6","volume":"56","author":"CC Zouboulis","year":"2005","unstructured":"Zouboulis CC, R\u00f6hrs H (2005) Kryochirurgische Behandlung aktinischer Keratosen mit evidenzbasierter \u00dcbersicht. Hautarzt 56:353\u2013358","journal-title":"Hautarzt"},{"key":"3873_CR45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-4632.2004.02056.x","volume":"43","author":"KE Thai","year":"2004","unstructured":"Thai KE, Fergin P, Freeman M (2004) A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol 43:687\u2013692","journal-title":"Int J Dermatol"},{"key":"3873_CR46","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1590\/abd1806-4841.20153302","volume":"90","author":"MC Oliveira","year":"2015","unstructured":"Oliveira MC (2015) Histopathological analysis of the therapeutic response to cryotherapy with liquid nitrogen in patients with multiple actinic keratosis. An Bras Dermatol 90:384\u2013389","journal-title":"An Bras Dermatol"},{"key":"3873_CR47","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.2008.08488.x","volume":"158","author":"R Kaufmann","year":"2008","unstructured":"Kaufmann R, Spelman L, Weightman W et al (2008) Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 158:994\u2013999","journal-title":"Br J Dermatol"},{"key":"3873_CR48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/mjd.2002.119649","volume":"47","author":"RM Szeimies","year":"2002","unstructured":"Szeimies RM, Karrer S, Radakovic-Fijan S et al (2002) Photodynamic therapy using topical methyl 5\u2011aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 47:258\u2013262","journal-title":"J Am Acad Dermatol"},{"key":"3873_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2340\/00015555-2175","volume":"96","author":"M \u00d6vermark","year":"2016","unstructured":"\u00d6vermark M, Koskenmies S, Pitk\u00e4nen S (2016) A retrospective study of treatment of squamous cell carcinoma in situ. Acta Derm Venereol 96:64\u201367","journal-title":"Acta Derm Venereol"},{"key":"3873_CR50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000367958","volume":"46","author":"K Vries de","year":"2015","unstructured":"de Vries K, Prens EP (2015) Laser treatment and its implications for photodamaged skin and actinic keratosis. Curr Probl Dermatol 46:129\u2013135","journal-title":"Curr Probl Dermatol"},{"key":"3873_CR51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/146288301753377852","volume":"3","author":"U Wollina","year":"2001","unstructured":"Wollina U, Konrad H, Karamfilov T (2001) Treatment of common warts and actinic keratoses by Er:YAG laser. J\u00a0Cutan Laser Ther 3:63\u201366","journal-title":"J Cutan Laser Ther"},{"key":"3873_CR52","first-page":"261","volume":"32","author":"JU Ostertag","year":"2006","unstructured":"Ostertag JU, Quaedvlieg PJ, Neumann MH et al (2006) Recurrence rates and long-term follow-up after laser resurfacing as a treatment for widespread actinic keratoses on the face and scalp. Dermatol Surg 32:261\u2013267","journal-title":"Dermatol Surg"},{"key":"3873_CR53","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1365-2133.2011.10387.x","volume":"165","author":"E Stockfleth","year":"2011","unstructured":"Stockfleth E, Kerl H, Zwingers T et al (2011) Low-dose 5\u2011fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol 165:1101\u20131108","journal-title":"Br J Dermatol"},{"key":"3873_CR54","first-page":"1","volume":"31","author":"HP Nguyen","year":"2016","unstructured":"Nguyen HP, Rivers JK (2016) Actikerall\u2122 (5-Fluorouracil 0.5\u202f% and Salicylic Acid 10\u202f%) topical solution for patient-directed treatment of actinic keratoses. Skin Therapy Lett 31:1\u20133","journal-title":"Skin Therapy Lett"},{"key":"3873_CR55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jdv.13445","volume":"30","author":"J Malvehy","year":"2016","unstructured":"Malvehy J, Alarcon I, Montoya J (2016) Treatment monitoring of 0.5\u202f% 5\u2011fluorouracil and 10\u202f% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy. J Eur Acad Dermatol Venereol 30:258\u2013265","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR56","first-page":"430","volume":"13","author":"RM Szeimies","year":"2015","unstructured":"Szeimies RM, Dirschka T, Prechtl A et al (2015) Efficacy of low-dose 5\u2011fluorouracil\/salicylic acid in actinic keratoses in relation to treatment duration. J Dtsch Dermatol Ges 13:430\u2013438","journal-title":"J Dtsch Dermatol Ges"},{"key":"3873_CR57","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1365-2133.2009.09040.x","volume":"160","author":"A Hauschild","year":"2009","unstructured":"Hauschild A, Stockfleth E, Popp G et al (2009) Optimization of photodynamic therapy with a novel self-adhesive 5\u2011aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 160:1066\u20131074","journal-title":"Br J Dermatol"},{"key":"3873_CR58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2133.2009.09377.x","volume":"162","author":"RM Szeimies","year":"2010","unstructured":"Szeimies RM, Stockfleth E, Popp G et al (2010) Long-term follow-up of photodynamic therapy with a self-adhesive 5\u2011aminolaevulinic acid patch: 12\u00a0months data. Br J Dermatol 162:410\u2013414","journal-title":"Br J Dermatol"},{"key":"3873_CR59","doi-asserted-by":"crossref","first-page":"e96829","DOI":"10.1371\/journal.pone.0096829","volume":"9","author":"S Vegter","year":"2014","unstructured":"Vegter S, Tolley K (2014) A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe. PLOS ONE 9:e96829","journal-title":"PLOS ONE"},{"key":"3873_CR60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14740338.7.2.167","volume":"7","author":"F Iraji","year":"2008","unstructured":"Iraji F, Siadat AH, Asilian A et\u00a0al (2008) The safety of diclofenac for the management and treatment of actinic keratoses. Expert Opin Drug Saf 7:167\u2013172","journal-title":"Expert Opin Drug Saf"},{"key":"3873_CR61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-1860","volume":"95","author":"J Malvehy","year":"2015","unstructured":"Malvehy J, Rold\u00e1n-Mar\u00edn R, Iglesias-Garc\u00eda P (2015) Monitoring treatment of field cancerisation with 3\u202f% diclofenac sodium 2.5\u202f% hyaluronic acid by reflectance confocal microscopy: a histologic correlation. Acta Derm Venereol 95:45\u201350","journal-title":"Acta Derm Venereol"},{"key":"3873_CR62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1468-3083.2011.04005.x","volume":"26","author":"A Pflugfelder","year":"2012","unstructured":"Pflugfelder A, Welter AK, Leiter U (2012) Open label randomized study comparing 3\u00a0months vs. 6\u00a0months treatment of actinic keratoses with 3\u202f% diclofenac in 2.5\u202f% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. J\u00a0Eur Acad Dermatol Venereol 26:48\u201353","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR63","first-page":"35","volume":"8","author":"B Shergill","year":"2013","unstructured":"Shergill B, Zokaie S, Carr AJ (2013) Non-adherence to topical treatments for actinic keratosis. Patient Prefer Adherence 8:35\u201341","journal-title":"Patient Prefer Adherence"},{"key":"3873_CR64","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","volume":"11","author":"M Lebwohl","year":"2012","unstructured":"Lebwohl M, Swanson N, Anderson LL et\u00a0al (2012) Ingenol mebutate gel for actinic keratosis. N Engl J Med 11:1010\u20131019","journal-title":"N Engl J Med"},{"key":"3873_CR65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.14222","volume":"3","author":"C Garbe","year":"2016","unstructured":"Garbe C, Basset-Seguin N, Poulin Y et al (2016) Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0.015\u202f% gel: a randomized, controlled 12-month study. Br J Dermatol 3:505\u2013513","journal-title":"Br J Dermatol"},{"key":"3873_CR66","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2013.2766","volume":"1479","author":"M Lebwohl","year":"2013","unstructured":"Lebwohl M, Shumack S, Stein Gold L et al (2013) Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol 1479:666\u2013670","journal-title":"JAMA Dermatol"},{"key":"3873_CR67","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jdv.13063","volume":"29","author":"LP Samorano","year":"2015","unstructured":"Samorano LP, Torezan LA, Sanches JA (2015) Evaluation of the tolerability and safety of a 0.015\u202f% ingenol mebutate gel compared to 5\u202f% 5\u2011fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial. J Eur Acad Dermatol Venereol 29:1822\u20131827","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR68","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jaad.2015.01.036","volume":"72","author":"M Augustin","year":"2015","unstructured":"Augustin M, Tu JH, Knudsen KM (2015) Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes. J\u00a0Am Acad Dermatol 72:816\u2013821","journal-title":"J Am Acad Dermatol"},{"key":"3873_CR69","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0149-2918(02)80012-1","volume":"24","author":"K Loven","year":"2002","unstructured":"Loven K, Stein L, Furst K et\u00a0al (2002) Evaluation of the efficacy and tolerability of 0.5\u202f% fluorouracil cream and 5\u202f% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 24:990\u20131000","journal-title":"Clin Ther"},{"key":"3873_CR70","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jamadermatol.2015.0502","volume":"151","author":"H Pomerantz","year":"2015","unstructured":"Pomerantz H, Hogan D, Eilers D et al (2015) Long-term efficacy of topical fluorouracil cream, 5\u202f%, for treating actinic keratosis: a randomized clinical trial. JAMA Dermatol 151:952\u2013960","journal-title":"JAMA Dermatol"},{"key":"3873_CR71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","volume":"157","author":"N Krawtchenko","year":"2007","unstructured":"Krawtchenko N, R\u00f6wert-Huber J, Ulrich M et al (2007) A randomised study of topical 5\u202f% imiquimod vs. topical 5\u2011fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1\u2011year follow-up. Br J Dermatol 157:34\u201340","journal-title":"Br J Dermatol"},{"key":"3873_CR72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2009.06.020","volume":"62","author":"CW Hanke","year":"2010","unstructured":"Hanke CW, Beer KR, Stockfleth E et al (2010) Imiquimod 2.5\u202f% and 3.75\u202f% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3\u2011week cycles. J Am Acad Dermatol 62:573\u2013581","journal-title":"J Am Acad Dermatol"},{"key":"3873_CR73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2340\/00015555-2167","volume":"96","author":"E Stockfleth","year":"2016","unstructured":"Stockfleth E, Sibbring GC, Alarcon I (2016) New topical treatment options for actinic keratosis: a systematic review. Acta Derm Venereol 96:17\u201322","journal-title":"Acta Derm Venereol"},{"key":"3873_CR74","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","volume":"141","author":"N Korman","year":"2005","unstructured":"Korman N, Moy R, Ling M et al (2005) Dosing with 5\u202f% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 141:467\u2013473","journal-title":"Arch Dermatol"},{"key":"3873_CR75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000323737","volume":"222","author":"J Santos-Juanes","year":"2011","unstructured":"Santos-Juanes J, Esteve A, Mas-Vidal A et al (2011) Acute renal failure caused by imiquimod 5\u202f% cream in a renal transplant patient: review of the literature on side effects of imiquimod. Dermatology 222:109\u2013112","journal-title":"Dermatology"},{"key":"3873_CR76","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00105-005-0950-5","volume":"56","author":"RM Szeimies","year":"2005","unstructured":"Szeimies RM, Karrer S, B\u00e4cker H (2005) Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma. Hautarzt 56:430\u2013440","journal-title":"Hautarzt"},{"key":"3873_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13206","author":"RM Szeimies","year":"2015","unstructured":"Szeimies RM (2015) A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe. J Eur Acad Dermatol Venereol. doi: 10.1111\/jdv.13206","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR78","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/bjd.12158","volume":"168","author":"T Dirschka","year":"2013","unstructured":"Dirschka T, Radny P, Dominicus R et al (2013) Long-term (6 and 12\u00a0months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol 168:825\u2013836","journal-title":"Br J Dermatol"},{"key":"3873_CR79","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000366548","volume":"46","author":"SR Wiegell","year":"2015","unstructured":"Wiegell SR (2015) Update on photodynamic treatment for actinic keratosis. Curr Probl Dermatol 46:122\u2013128","journal-title":"Curr Probl Dermatol"},{"key":"3873_CR80","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2133.2012.10887.x","volume":"167","author":"RM Szeimies","year":"2012","unstructured":"Szeimies RM, Torezan L, Niwa A et\u00a0al (2012) Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol 167:150\u2013159","journal-title":"Br J Dermatol"},{"key":"3873_CR81","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2133.2008.08450.x","volume":"158","author":"SR Wiegell","year":"2008","unstructured":"Wiegell SR, Haedersdal M, Philipsen PA et al (2008) Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 158:740\u2013746","journal-title":"Br J Dermatol"},{"key":"3873_CR82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1468-3083.2011.04386.x","volume":"26","author":"SR Wiegell","year":"2012","unstructured":"Wiegell SR, Wulf HC, Szeimies RM et\u00a0al (2012) Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J\u00a0Eur Acad Dermatol Venereol 26:673\u2013679","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR83","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jdv.13228","volume":"29","author":"JP Lacour","year":"2015","unstructured":"Lacour JP, Ulrich C, Gilaberte Y et al (2015) Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol 29:2342\u20132348","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR84","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.13076","volume":"29","author":"MC Fargnoli","year":"2015","unstructured":"Fargnoli MC, Piccioni A, Neri L et al (2015) Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy. J Eur Acad Dermatol Venereol 29:1926\u20131932","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3873_CR85","first-page":"632","volume":"11","author":"RM Szeimies","year":"2013","unstructured":"Szeimies RM, Lischner S, Philipp-Dormston W et al (2013) Photodynamic therapy for skin rejuvenation: treatment options - results of a\u00a0consensus conference of an expert group for aesthetic photodynamic therapy. J Dtsch Dermatol Ges 11:632\u2013636","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3873-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3873-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3873-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:51:46Z","timestamp":1601070706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3873-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3873"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3873-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}